Chemical ID: CAS Formula HS Code Database — 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose

Product Identification

Parameter	Technical Commentary
Product Name & IUPAC Name	1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose IUPAC: (2R,3R,4S,5R)-2,3,5-Triacetoxy-4-hydroxyoxolane-2-carboxylic acid ethyl ester (common variants exist; naming conventions may vary with supplier or grade).
Chemical Formula	C14H18O9
CAS Number	13035-61-5
Synonyms & Trade Names	Common synonyms include Tetraacetylribose, Peracetyl-β-D-ribofuranose. Specific synonym use can reflect target application or end-market. Trade names, if any, are not standardized and depend on manufacturer branding and region.
HS Code & Customs Classification	Typical import/export classification falls under HS Code 2940.00 (Sugars, chemically pure, and their ethers, esters, and salts). Interpretation at customs may differ by jurisdiction, especially for research or pharmaceutical grades, so declarants routinely review both the raw material origin and product end use against local tariff annotations. Non-harmonized reporting can occur due to overlap with starting sugar intermediates.

Technical Discussion on Identification & Classification

Product purity, stereochemistry, and the number of acetyl groups require robust analytical confirmation. Production lines making this compound standardize acetylation and purification steps based on grade requirement. In our facility, the primary drivers in route selection are the desired enantiomeric purity and extent of downstream conversion to nucleoside or nucleotide intermediates. HS Code assignment has posed challenges, particularly for customers transitioning between research and commercial scales or where end products cross boundaries between reagents and active pharmaceutical ingredient intermediates. We frequently supply product accompanied by detailed analytics to satisfy both customs and regulatory import checks, as arbitrary classification delays can disrupt delivery to formulation plants or R&D partners.

In all cases, identity and documentation transparency are prioritized, as ambiguous naming or formula listing often leads to shipment holds at customs, delays in production schedules, and risk of product misallocation. Our technical documentation reflects careful alignment with actual synthesis route, dehydration/acylation process impurities, and batch traceability, ensuring each shipment meets the relevant industrial and regulatory standards expected downstream.

Technical Properties, Manufacturing Process & Safety Guidelines
1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose

Physical & Chemical Properties

Physical State & Appearance

Industrial batches of 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose typically appear as a white or off-white crystalline solid. Any off-coloration, depending on the synthesis path or raw material purity, signals either side reactions or trace metal contamination. Tight color and form controls are crucial in pharmaceutical applications that rely on acetylated sugars as intermediates.

The material shows negligible odor; a strong or unusual smell points to residual acetic acid or other by-products that slipped the purification process. Melting point varies slightly with residue solvent content and grade but falls within the defined range for release. Boiling point is of less industrial concern due to product decomposition before reaching such temperatures. Flash points are not a primary parameter, as this compound is non-volatile and is not used in heated transfers. Density can vary depending on crystallization solvent and drying conditions.

Chemical Stability & Reactivity

Acetylated sugars are particularly sensitive to moisture and basic conditions; the compound undergoes hydrolysis in aqueous or high-humidity environments, which must be tightly controlled in storage and handling. It shows no hazardous reactivity under neutral, dry, low-temperature process conditions but will degrade rapidly in alkaline or catalytic hydrogenation scenarios.

Solubility & Solution Preparation

Solubility depends strongly on solvent polarity and temperature. Pure, dry material dissolves completely in most organic solvents like dichloromethane, chloroform, and ethyl acetate. Residual solvent content or impurities in crude grades significantly alter solubility profiles, influencing crystallization and downstream derivatization. Solution preparation for analytical or preparative work requires dry conditions to avoid unwanted hydrolysis. Hydrated or impure grades tend to form suspensions rather than true solutions.

Technical Specifications & Quality Parameters

Specification Table by Grade

Specification limits vary markedly: pharma/intermediate grades demand highly restricted impurity levels and minimal residual solvents, while technical grades may carry broader ranges. Commercial contracts define these specifics, which originate from the end-use and customer’s regulatory environment.

Parameter	Pharmaceutical Grade	Technical Grade
Appearance	White crystalline	Off-white to white crystalline
Assay (HPLC/GC)	Defined by customer spec	Defined by customer spec
Moisture (KF)	Application-sensitive	Application-sensitive
Single impurity	Grade-dependent	Grade-dependent

Impurity Profile & Limits

Crude material from the first acetylation can show colored by-products, residual acetic acid, or catalyst traces. Downstream purification (recrystallization, filtration) strips most organic and inorganic impurities, but certain trace levels remain grade and process dependent. Process design targets limit setting for key impurities—especially those relevant under ICH Q3A/B in pharma contexts. Actual routine impurity levels rely on both parent ribose quality and in-process monitoring.

Test Methods & Standards

Analytical teams rely on HPLC for purity/assay, with physical constants (melting point, IR, NMR) as supporting tests. Test tolerances and methods are locked to either in-house standards or international compendial requirements, with protocols validated to customer demands or local regulatory frameworks.

Preparation Methods & Manufacturing Process

Raw Materials & Sourcing

Source selection starts with high-purity D-ribose and acetic anhydride. Cost and impurity profile of ribose affect solvent choice, catalyst load, and acetylation efficiency. Inconsistent raw material quality triggers more complex process control and higher purification costs down the line.

Synthesis Route & Reaction Mechanism

Industrial production follows direct acetylation of β-D-ribofuranose using acetic anhydride and an acid catalyst, classically pyridine or alternative amine bases. Side-products arise from over-acetylation or ring-opening reactions, especially at elevated temperatures or in impure substrate batches.

Process Control & Purification

Key control points include temperature management, reactant stoichiometry, and moisture exclusion throughout reaction and workup. Acidic by-products must be washed off thoroughly to prevent off-odors and downstream stability problems. Final purification typically uses selective crystallization or solvent extraction, dictated by the impurity pattern and customer quality needs.

Quality Control & Batch Release

Final batch release depends on grade, customer requirements, and internal quality policy. Routine batches pass through multiple analytical checks: assay by HPLC, moisture profiling by Karl Fischer, and appearance review. Any deviation in impurity load, moisture, or color leads to reprocessing or off-grade allocation.

Chemical Reactions & Modification Potential

Typical Reactions

This acetylated ribofuranose serves as a key glycosyl donor in nucleoside and carbohydrate chemistry. Deprotection, transesterification, and glycosylation occur under controlled acid, base, or enzymatic conditions, adjusted for downstream product selectivity.

Reaction Conditions

Typical conditions require organic solvents, exclusion of moisture, and temperature adjustment according to target derivative. Catalyst choice—often Lewis acids or bases—directly impacts reaction speed and selectivity. For pharmaceutical intermediates, narrow process windows are set to minimize byproduct and maximize yield.

Derivatives & Downstream Products

The compound generates a wide array of functionalized carbohydrates, nucleosides, and nucleotide analogues after selective deprotection or modification. Derivative routes call for prescription-grade starting material to meet drug master file (DMF) or regulatory expectations.

Storage & Shelf Life

Storage Conditions

Product integrity depends on cool, dry storage in sealed, light-resistant packaging. High humidity or exposure to air causes gradual hydrolysis, leading to increased levels of deacetylated sugar as shown by routine QC checks.

Avoid contact with iron or other metallic containers, which may catalyze degradation or tint the product. Packaging in inert-gas-flushed, food-grade plastic or glass maintains product within specification through shipment and storage.

Container Compatibility

Stable in compatible plastics or glass; some metals prompt unwanted side reactions or browning. Packaging reviews examine leachables and contamination potentials according to end-use grade.

Shelf Life & Degradation Signs

Shelf life depends on grade, final packaging, and transit/storage conditions. Typical degradation includes color change, melting range shift, or lowering assay by hydrolysis. Manufacturers specify internal shelf life after comprehensive stability studies and on real-world transportation conditions.

Safety & Toxicity Profile

GHS Classification

No acute hazards documented under normal industrial handling. This class of acetylated sugars generally receives non-hazardous handling status; actual classification requires reference to most recent GHS update and region-specific inventories.

Hazard & Precautionary Statements

Direct contact with eyes or prolonged skin exposure may provoke irritation, largely due to trace acetic acid or unreacted catalyst remnants. Well-ventilated environments and standard PPE (nitrile gloves, goggles, lab coats) are standard site requirements.

Toxicity Data

Available toxicity data points to low acute oral and dermal toxicity, but chronic or repeated exposure studies are limited. Manufacturing practice avoids ingestion or long-term skin contact by enforcing closed system charging and discharge.

Exposure Limits & Handling

Regulatory bodies do not define mandatory exposure limits for this compound, though industry practice maintains operator exposure well under generic nuisance dust or organic vapor guidelines. Dust extraction, proper ventilation, and personnel protective training form the foundation of safe handling strategy.

Supply Capacity & Commercial Terms for 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose

Production Capacity & Availability

Production hinges on the stability of key raw materials such as acetic anhydride and D-ribose derivatives. Scheduling uses batch or semi-continuous processes, with actual output limited by the purity targets and client grade specifications. Annual output capacity varies with grade: research-grade typically has tighter purity, cGMP-grade for API intermediates involves longer quality review and batch documentation cycles. Availability depends on campaign scheduling, validation status, and reserve allocation for long-term customers.

Lead Time & Minimum Order Quantity (MOQ)

Lead time is influenced by campaign planning and whether a batch requires new validation or is drawn from qualified stock. MOQs are defined per customer application: small batches possible for specialty pharma and diagnostic clients, while bulk supply typically starts at the drum-scale. Repeat orders for the same specification see shorter lead times compared to custom specifications or higher-purity requests.

Packaging Options

Packaging varies by grade, with sealed HDPE drums standard for technical and bulk grades. High-purity batches may require double-packaging and inert atmospheric conditions. Documentation for packaging includes traceability coding and records for pharmaceutical customers. Selection aligns with product sensitivity and downstream handling requirements.

Shipping & Payment Terms

Shipping is dictated by destination regulatory constraints: cold chain, inert atmosphere, or export declaration may be required for sensitive or high-value grades. Terms most commonly align with Incoterms EXW or FOB; payment cycles depend on customer risk profile and volume contract structure. Advance payment or letter of credit prevails for new importers, while established clients may negotiate longer payment windows.

Pricing Structure & Influencing Factors

Raw Material Cost Composition & Fluctuation Drivers

Key contributors to cost include the pricing for high-purity D-ribose, acetic anhydride cost swings, process solvent pricing, and utilities during acetylation and purification. Feedstock price swings stem from agriculture (fermentation) for D-ribose, and from petrochemicals for acetic anhydride. Run-to-run variations arise when sourcing requires qualified suppliers due to regulatory or impurity profile shifts. For pharmaceutical-grade, overhead from compliance (GMP documentation, third-party audits) and waste management increases cost base significantly.

Explanation of Price Difference: Grade, Purity, and Packaging Certification

Grade determines in-process control intensity and necessity for full impurity mapping. Pharmaceutical and diagnostic customers pay premiums tied to batch documentation traceability, validated impurity profiling, and packaging certification to minimize cross-contamination risk. Pricing shifts based on release purity, residual solvent control, and certified packaging. Technical grade uses bulk packaging and streamlined QC tests, reflected in lower cost.

Global Market Analysis & Price Trends

Global Supply & Demand Overview

Production facilities mainly operate in East Asia and Europe, driven by clustering near source material synthesis plants and pharma contract manufacturing hubs. Demand cycles track with pharmaceutical intermediate usage, nucleoside-based API innovations, and diagnostic kit manufacturing expansion. Production disruptions—often from raw material feedstock shortages or logistics bottlenecks—add volatility to spot and contract pricing.

Key Economies Analysis (US, EU, JP, IN, CN)

The US and EU prioritize compliance-verified material, adding regulatory overhead that narrows supplier eligibility. China and India see higher volume movement, especially for technical grade, often reflecting more streamlined or less documented processes for domestic use. Japan’s market prefers ultra-consistent, high-purity material, with pricing reflecting strict acceptance criteria and lower tolerance for off-grade batches.

2026 Price Trend Forecast, Data Sources & Methodology

Assuming no major shift in agricultural and solvent commodity prices or sudden regulatory overhauls, pricing by 2026 is projected to edge up, with pharmaceutical-grade likely to see more pronounced increases. Drivers: incremental GMP compliance costs, more detailed impurity mapping, packaging audits, and periodic spikes when solvent markets tighten. Methodology draws on trailing three-year supply contract data, raw material spot pricing indices, and published regulatory trend communications.

Industry News & Regulatory Updates

Recent Market Developments

Recent quarters saw increased audits of acetic anhydride sources, reflecting tighter anti-diversion oversight in Western markets and new requirements for detailed supplier certification. Some producers have adapted by localizing more of their feedstock streams to reduce import dependency and hedge against global logistics risk.

Regulatory Compliance Updates

Major regulatory shifts include updates to nitrosamine evaluation protocols and introduction of expanded impurity release testing for cGMP relevant grades. In some regions, packaging is now subject to stricter traceability and material conformance regulations, prompting additional documentation and testing for high-purity batches.

Supplier Response & Mitigation

Producers have adjusted by reinforcing traceability systems, batch archival, and extending supplier assessments—especially for API intermediate applications. Some expanded cleanroom packaging capability in response to new purity and contamination risk guidance. Where needed, process flowsheets now include extra purification steps or alternative solvent quenching to address evolving impurity requirements and customer audit findings.

Application Fields & Grade Selection Guide for 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose

Industry Applications

Manufacturers source 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose primarily for nucleoside synthesis, nucleotide antiviral and anticancer intermediates, and fine chemical R&D. Application context dictates requirements for purity, elemental profile, and residual solvent presence. In our experience, pharmaceutical intermediate producers monitor residual moisture, acetic acid, and unreacted building blocks closely due to their direct impact on subsequent reaction yields and impurity profiles in final APIs. Custom synthesis facilities often demand project-specific impurity control or modified particle characteristics to fit continuous flow or batch process integration. Some materials science routes utilize this compound for specialty coatings and microelectronic development, expecting tailored crystallinity and metal ion baseline.

Grade-to-Application Mapping

Grade	Typical Application Areas	Key Parameter Focus
High Purity (Pharma/Injectable)	API intermediates, nucleotide analogs, DNA/RNA research	Purity, trace metals, specific optical rotation, residual solvents, bioburden
Reagent Grade	R&D synthesis, diagnostics, pilot-to-scale process trials	Residual starting material, water content, co-crystallized solvents
Standard Industrial	Bulk synthesis, specialty polymers, non-therapeutic applications	Bulk stability, color, as-is melt behavior, cost/performance balance

Key Parameters by Application

Process development teams often seek clear guidance on inorganic impurity baselines, especially for regulated pharmaceutical projects. Moisture content, by Karl Fischer or equivalent, influences crystallization and storage performance in humid climates—requiring frequent batch-level testing. Particulate cleanliness comes to the fore in microelectronic applications; filtration practices and packaging integrity checks contribute substantially to grade certification here. Bioburden and endotoxin assessment are included for injectable-use intermediates, especially where downstream bioprocessing omits dedicated kill steps. Acetyl group integrity matters for chemistries reliant on selective deprotection; batch-level NMR and IR screening are routine release controls to verify product structure.

How to Select the Right Grade

Step 1: Define Application

Align target use (API intermediate, lab R&D, specialty chemical, microelectronics) to principal grade. Each field presents unique risks if contaminants or off-spec attributes propagate into further process steps.

Step 2: Identify Regulatory Requirements

Define whether target application falls under GMP, cGMP, or research-exempt processes. Engage with regulatory guidance to determine if low-endotoxin, low-metal, or specific solvent residue thresholds apply. Manufacturer experience shows more diligent up-front assessment prevents costly downstream remediation or rejection.

Step 3: Evaluate Purity Needs

Assess batch-specific needs for HPLC purity, stereoisomeric ratio, and critical impurity cutoffs. Select process route and purification regime (e.g., column, crystallization, recrystallization) based on achievable profile. Some customers specify limits for unidentified single impurities to mitigate unknowns in downstream synthesis.

Step 4: Consider Volume & Budget

Establish project scale (gram to ton). Pilot users typically seek flexible packaging; scale-up requires logistics on just-in-time production and batch reserve. Balancing purity and cost—especially at industrial volume—often swings process route or batch size selection.

Step 5: Request Sample for Validation

Technical teams benefit from bench-scale validation of supplied grade. Analytical cross-check, solubility testing, and compatibility assessment with intended solvents or reagents reveal practical suitability and batch-to-batch consistency.

Manufacturing & Quality Control Considerations

Raw Material Selection Logic

Sourcing of D-ribose and acetylating agents rests on vendor qualification—microbial, elemental, and residual solvent backgrounds must support downstream purity. Process route diverges for GMP and non-GMP grades to isolate contamination risks. Quality teams periodically audit supplier analytics, as upstream variability drives batch reprocessing costs.

Process Route Selection & Key Control Points

Batch acetylation, monitored for completeness by TLC or HPLC, dominates standard production. Exotherm and potential for byproduct formation (e.g., tri- or mono-acetyl ribose) require tight temperature and reagent addition control. In-process sampling at key conversion points ensures high control on degree of substitution. Experienced operators can adjust solvent selection at recrystallization stage to tune impurity carry-over or batch yield.

Impurity Generation & Purification Strategy

Process impurities include over-acetylation, acetic acid remnant, and rarely, colored bodies from degraded starting material. High-purity and pharma grades undergo multi-stage purification: activated carbon, repeated crystallizations, and final filtration. Each stage validated for removal efficiency—typical values depend on grade and customer standard.

Batch Consistency Management

Quality control programs use reference standard comparison to ensure spectral, melting range, and impurity baseline consistency across lots. Data from process analytics and out-of-trend excursions undergo periodic review; deviations flagged for internal investigation. Feedback from customer process performance sometimes drives refinement to process parameters or packaging.

Release Criteria

Final release standards tie to product grade and customer specification. Release analytics include at minimum: HPLC purity, identity by NMR, moisture, color, specific rotation, and defined impurity spectrum. Additional bioburden or pyrogen testing applies as required for each application. The final release standard is subject to internal quality control criteria and customer requirements.

Trust & Compliance: Quality Certifications & Procurement Support for 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose

Quality Compliance & Certifications

Quality Management Certifications

The production of 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose is governed by a formal quality management framework. Our facilities operate under ISO-certified systems, with internal audits scheduled to track adherence to documented procedures. Consistency is tested batch-to-batch through in-process checks, qualification of equipment, and validation of cleaning procedures.

Selection and monitoring of raw material suppliers include traceability back to each consignment. Analytical instrumentation undergoes regular calibration, with records maintained for each lot release. Retention samples and production records are archived for post-shipment review as required by internal protocols and contractual agreements.

Product-Specific Certifications

Where customer or regulatory requirements dictate, our technical team supports certifications such as GMP compliance (for grades supplied into API or intermediate streams), or conformance to REACH and other international schemes for industrial-grade product. Conformity depends on the intended use and grade classification. Each project is assessed for need-based certification—ranging from food, pharma, to special industrial grades—and the certification route is tailored accordingly.

Documentation & Reports

Full CoA is released based on in-house analytical test results that reflect batch quality at time of shipment. Typical data includes physical appearance, principal assay (chromatography-based), and key impurity profiles, each defined according to grade and specification agreement. Detailed analytical method documents, MSDS, and TDS are provided upon request. Release standards for each consignment are grade-specific and documented, with certificates attached to shipped lots and archived for traceability.

Purchase Cooperation Instructions

Stable Production Capacity Supply and Flexible Business Cooperation Plan

Production scheduling prioritizes long-term partners and program-based customers to minimize supply disruption. Our plant design supports campaign and continuous production based on forecasted offtake, enabling us to accommodate both large-scale contracts and smaller, project-based demands. Forecast-driven capacity planning allows for allocation of manufacturing windows based on client lead times and periodic volume reviews.

Core Production Capacity and Stable Supply Capability

Key intermediates, including 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose, rely on secure upstream sources and backward-integrated raw material routes where possible. Multi-reactor setups and validated process controls ensure consistent output. Demand surges are addressed by parallel production lines and redundancy in critical equipment. Batch records, consumption rates, and downtime logs are reviewed regularly to ensure throughput targets are held even under challenging conditions.

Sample Application Process

Sample requests are coordinated through technical account managers. Each request initiates an internal evaluation based on the end-use, grade requirement, and intended application. Analytical data provided with samples align with customer-specified test parameters. Verification lots echo the actual process used in routine production, representing full-scale batch protocols and control limits.

Detailed Explanation of Flexible Cooperation Mode

Business models support toll manufacturing, joint development, and contract production based on customer preference or project needs. Framework agreements may include buffer inventory programs, rolling forecasts, and volume-based pricing triggers. Customers can opt for long-term fixed price contracts, just-in-time deliveries, or upscaling trial campaigns. Terms are tailored after technical alignment and supply risk assessments, with technical, quality, and logistics teams actively involved from project qualification to post-shipment support.

Market Forecast & Technical Support System for 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose

Research & Development Trends

Current R&D Hotspots

Research into 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose continues to track the needs of nucleoside active pharmaceutical ingredient (API) synthesis and the development of next-generation nucleotide analogues. The major R&D focus has shifted as demand has risen for nucleoside building blocks compatible with automated solid-phase oligonucleotide synthesis, as well as for intermediates enabling improved yields and reduced by-products in high-value pharma routes. Selection of protective groups and reaction conditions is being evaluated for both cost efficiency and compatibility with green chemistry aims, with acetylation steps and deprotection strategies recently seeing renewed optimization efforts.

Emerging Applications

Sustained progress in mRNA vaccine production and expanding gene therapy pipelines have drawn interest towards scalable, high-purity sources of protected ribose derivatives. In the diagnostic reagent sector, newly refined formats for enzyme-linked immunosorbent assays (ELISAs) and PCR kits have pushed for lower extractables and leachables during oligonucleotide probe manufacture. Certain nucleoside derivative markets, especially in modified RNA and antisense oligos, now demand batch-specific impurity profiling beyond standard residual solvents or inorganic contaminants.

Technical Challenges & Breakthroughs

Industrial producers address several technical roadblocks: removal of regioisomeric impurities, control of anomer ratios, and minimization of colored by-products related to underacetylation or overexposure to catalyst residues. Process improvements have centered around refining acetylation catalysts, adjusting stoichiometries, and optimizing solvent recycling to mitigate process-waste loads. Purification strategies increasingly incorporate membrane separation or advanced crystallization protocols, responding directly to rising requirements for batch reproducibility and raw material traceability. Adaptations in in-process analytics now allow for tailored reaction monitoring based on final customer control points rather than generic release tests.

Future Outlook

Market Forecast (3-5 Years)

Our manufacturing forecasts are based on customer order patterns in the pharma and research reagent industries. Demand for 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose displays sensitivity to cycles in both high-throughput oligo synthesis for diagnostics and the release of new RNA-based drugs. Global regulatory framework evolution—especially in markets with stringent impurity control—drives the growth of differentiated grades. The forecasted application split favors nucleoside intermediate supply, but with clear secondary growth from bioprocessing and custom reagent production.

Technological Evolution

Incremental improvements in low-waste acetylation chemistry, together with closed-loop solvent regeneration and in-line impurity stripping, are gaining traction. Direct coupling to downstream nucleoside synthesis without intermediate purification is on the horizon, as is real-time monitoring for critical impurities. Trends indicate a shift away from legacy chlorinated solvents, favoring alternatives that simplify downstream compliance for pharmaceutical customers.

Sustainability & Green Chemistry

Pressure to decarbonize and reduce process emissions guides raw material choice, with a swing towards bio-based D-ribose and solvent minimization protocols. Green chemistry frameworks now govern new process deployment. The acetyl donor’s sourcing and reagent recovery rates directly affect both price structure and acceptance in life sciences markets. Regulatory dynamics increasingly require lifecycle documentation, including waste management and potential for cross-contamination, pushing manufacturers to revisit every step from raw material sourcing to packaging.

Technical Support & After-Sales Service

Technical Consultation

Our technical department supports formulators and process engineers with recommendations on grade selection, expected impurity profiles by synthesis route, and strategies for impurity removal. Advice always reflects actual process history, incorporating both laboratory findings and scale-up lessons. When customers present special requirements, such as atypical crystallization behavior or solvent compatibility, support is tailored based on batch data and prior manufacturing runs, not theoretical models.

Application Optimization Support

We work directly with R&D teams to troubleshoot formulation bottlenecks, such as acetyl group migration or variable solubility in specific solvents. When clients require repeatable performance in automated dispensers, we assist with adjustment of granulometry and moisture control routines, always verifying effects on downstream synthesis performance. For grades used in clinical pipelines or regulated manufacturing, all recommendations flow from tested scale-up protocols and validated control points.

After-Sales Commitment

Each supplied batch carries traceable lot history and can reference in-process control records by request. If a shipped lot displays deviations in intended performance—such as unexpected impurity carryover or physical characteristics outside mutually agreed tolerances—our quality control and production teams jointly support root cause evaluations and corrective actions. Ongoing feedback from customer implementations grounds our annual review of specifications and informs continuous improvement programs at site and raw material supplier level. Extended technical assistance and requalification support remain available for any changes in downstream application or process modifications.

Manufacturing High-Purity 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose for Commercial Use

As a dedicated producer of 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose, we approach every batch with a focus on technical integrity and industrial reliability. From raw material sourcing through the final drying stage, every step in our process aims at delivering consistent product outcomes for scale-up operations in demanding sectors.

Controlled Manufacturing from Raw Material to Finished Bulk

Our synthesis line uses strictly profiled D-ribose and high-quality acetic anhydride. Process control limits downstream variability and supports predictable results in acylation and purification. We operate closed-cycle production with dedicated vessels to limit exposure and cross-contamination, essential for large-scale enzyme and nucleoside synthesis industries.

Industrial Applications Driven by Performance Requirements

1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose plays a key role in the synthesis of nucleoside analogs, including intermediates for antiviral and anticancer actives. Pharmaceutical plants and fine chemical manufacturers depend on our product as a primary building block for research and full-scale manufacture. Our consistency supports workflow in R&D, pilot batches, and multi-ton commercial runs without interruption in reactivity or yield.

Product Consistency and Quality Control Protocols

We commit to fixed analytical protocols, including HPLC and NMR monitoring for every batch. Moisture and residual solvent levels fall within narrow targets. Our lab validates carbohydrate purity to support downstream conversions without reagent waste or side-product accumulation. Each production lot receives a full release certificate with traceable QC signatures, not just standard paperwork. This oversight removes production risks for buyers focused on regulated markets.

Bulk Packaging and Supply Capabilities

We offer the compound in HDPE drums and lined fiber cartons sized for secure loading and easy drum handling. Internal logistics teams coordinate palletizing and drum protection, minimizing risk during ocean or road freight. Reorder volumes ship from our on-site warehousing, bypassing the delays and quality drift that affects non-integrated supply chains. Customers planning multi-month campaigns depend on timely deliveries direct from our inventory stock, not rolling purchase orders or fragmented consignment.

Technical Support Tailored to Process Integration

Process engineers from our facility respond directly to technical inquiries about solubility behavior, scaling parameters, and reactivity. We share track record data for downstream protection strategies and filtration. Industrial buyers receive practical guidance to keep new campaign trials in-spec and help with regulatory documentation as needed for each endpoint application. This interface extends beyond first purchase, ensuring long-term collaboration on process upscaling and cost-of-goods reduction.

Business Value for Manufacturers, Distributors, and Procurement Teams

Direct manufacturing assures buyers of price transparency, batch traceability, and consistent support through every purchasing cycle. Procurement teams gain a reliable partner with oversight of all variables affecting lead time, batch quality, and shipment predictability. Distributors working with us access a stable, factory-direct inventory, giving them confidence when planning for their own clients’ cyclical or project-based demand. Our value lies in committed technical partnership, delivery reliability, and quality discipline built through every phase of chemical production—not intermediary trade.

Industrial FAQ